Search Results 531-540 of 21425 for anti-TNF drugs

1. Infectious diseases - Diagnosis & treatment - Mayo Clinic

   More-severe internal organ fungal infections, especially in people with weakened immune systems, may require intravenous antifungal medications. Anti-parasitics.

2. Corticosteroid (Dental Route) Description and Brand Names - Mayo Clinic

   Descriptions. Dental corticosteroids are used to relieve the discomfort and redness of some mouth and gum problems. These medicines are like cortisone. They ...

3. Milk thistle - Mayo Clinic

   Milk thistle may affect how your liver processes this osteoporosis medication, causing higher levels of the drug in your bloodstream. Talk to your doctor before ...

4. Sulfonamide (Oral Route) Before Using - Mayo Clinic

   Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

5. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...

6. Zinc - Mayo Clinic

   People use oral zinc to help treat colds, but it can decrease the effectiveness of certain drugs and cause side effects. ... These blood pressure drugs increase ...

7. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

8. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

   Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

9. Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care - Mayo Clinic News Network

   Dual blockade using two anti-HER2 drugs only increased toxicity, said Dr. Perez. This new analysis compared use of lapatinib or trastuzumab alone, as well ...

10. Thrombin Human, Recombinant (Topical Application Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Recothrom. Canadian Brand Name. Thrombinar ...